Neuronal SEL1L-HRD1 ER-associated degradation is essential for motor function and survival in mice
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci196819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Mauricio Torres und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Neurons, Ubiquitin-Protein Ligases, Proteins, Endoplasmic Reticulum-Associated Degradation. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Hypomorphic variants in the SEL1L-HRD1 ER-associated degradation (ERAD) complex have been linked to severe neurological syndromes in children, including neurodevelopmental delay, intellectual disability, motor dysfunction, and early death. Despite this association, its physiological importance and underlying mechanisms in neurons remain poorly understood. Here, we show that neuronal SEL1L-HRD1 ERAD is essential for maintaining one-carbon metabolism, motor function, and overall viability. Neuron-specific deletion of Sel1L in mice (Sel1LSynCre) resulted in growth retardation, severe motor impairments, and early mortality by 9 weeks of age - mirroring core clinical features observed in affected patients - despite preserved neuronal numbers and only modest ER stress. Multiomics analyses, including single-nucleus RNA sequencing and metabolomics, revealed significant dysregulation of one-carbon metabolism in ERAD-deficient brains. This included activation of the serine, folate, and methionine pathways, accompanied by elevated levels of S-adenosylmethionine and related metabolites, likely resulting from induction of the integrated stress response. Together, these findings uncover a previously unappreciated role for neuronal SEL1L-HRD1 ERAD in coordinating ER protein quality control with metabolic adaptation, providing insight into the molecular basis of ERAD-related neurodevelopmental disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
- Department of Molecular & Integrative Physiology and.
- Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Radiation Oncology and.
- Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Zilkha Neurogenetic Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- NIDDK NIH HHS
- Alzheimer’s Association
- NIH NINDS
- NIH NIA
Zitieren
APA
Torres, M., Lu, Y., Pederson, B., Wang, H., Gretzinger, A., Lin, L. L., Hwang, J., Chen, X., Rupp, A. C., Tomlinson, A. J., Scott, A. J., Zhao, Z., Wahl, D. R., Myers, M. G., Lyssiotis, C. A., & Qi, L. (2026). Neuronal SEL1L-HRD1 ER-associated degradation is essential for motor function and survival in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci196819
Vancouver
Torres M, Lu Y, Pederson B, Wang H, Gretzinger A, Lin LL, et al. Neuronal SEL1L-HRD1 ER-associated degradation is essential for motor function and survival in mice. Journal of Clinical Investigation. 2026. doi:10.1172/jci196819
BibTeX
@article{Torres2026,
author = {Torres, Mauricio and Lu, You and Pederson, Brent and Wang, Hui and Gretzinger, Anna and Lin, Liangguang L and Hwang, Jiwon and Chen, Xinxin and Rupp, Alan C and Tomlinson, Abigail J and Scott, Andrew J and Zhao, Zhen and Wahl, Daniel R and Myers, Martin G and Lyssiotis, Costas A and Qi, Ling},
title = {Neuronal SEL1L-HRD1 ER-associated degradation is essential for motor function and survival in mice},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci196819}
}
EUVIMED